RNU7-49P

Across TCGA pan-cancer cohorts, RNU7-49P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RNU7-49P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RNU7-49P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU7-49P is over-expressed in tumor.

KIRC, CHOL, and HNSC are the cancer types where RNU7-49P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU7-49P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.642	<.001	7	view →
CHOL	Female	All	+2.026	.003	2	view →
HNSC	Female	All	+0.731	.028	2	view →
PRAD	All	All	+0.426	.037	2	view →
LIHC	All	All	+0.366	.024	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RNU7-49P–KIRC

Open the KIRC breakdown →